Publikasi Scopus 2024 per tanggal 31 Juli 2024 (607 artikel)

Management of chronic heart failure has been much more complex due to emergence of challenge in the treatment of heart failure and the underlying etiology simultaneously. The presence of arrhythmia may have adverse effects on long-term cardiac remodeling. Arrhythmia in chronic heart failure is exacerbated by overstimulation of neurohormonal system, which causes oxidative stress, inflammation, electrolyte imbalance, aggravating risk of increased arrhythmogenesis. As increase in QRS and QT prolongation predispose arrhythmogenesis, various types of tachyarrhythmia require guideline in the management to be specifically tailored to heart failure patients, such as adenosine in terminating supraventricular tachycardia, beta blocker for atrial fibrillation in heart failure, or class 1C antiarrhythmic medication for stable ventricular tachycardia. Furthermore, dysfunction of pacemaker nodes favors and needs arrhythmia complication. Patients with heart failure who developed arrhythmias present major artificial pacemaker installed with resynchronization mode, resolving conduction block in strained heart tissues. Understanding pathophysiology of arrhythmia classification in heart failure may assist in choosing appropriate management for patients, with increase in quality of life in these patients and reducing rate of morbidity and mortality. © 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.